Over the last 12 months, Merit Medical Systems insiders reported 4 buys totaling $474K and 8 sales totaling $8.5M across SEC Form 4 filings. 8% of those filings were made under pre-arranged 10b5-1 trading plans.
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 24, 2026 | Peterson Neil W.CHIEF OPERATING OFFICER · O | ▼ Sale | 7,500 | $90.45 | $678K | -29.4% | — |
| Aug 4, 2026 | Peterson Neil W.CHIEF OPERATING OFFICER · O | ▼ Sale | 21,449 | $85 | $1.8M | -45.6% | — |
| May 7, 2026 | Ward Lynne N.D | ▼ Sale | 5,000 | $62.61 | $313K | -39% | — |
| May 7, 2026 | Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY · O | ▲ Buy | 2,000 | $62.62 | $125K | — | indirect |
| May 6, 2026 | Parra Raul Jr.CFO AND TREASURER · O | ▲ Buy | 1,500 | $61.01 | $92K | +2.6% | — |
| May 6, 2026 | Aronson Martha GoldbergPresident and CEO · O·D | ▲ Buy | 2,000 | $60.44 | $121K | +4.2% | — |
| May 5, 2026 | Voigt Michel J.CHIEF HUMAN RESOURCES OFFICER · O | ▲ Buy | 2,250 | $60.65 | $136K | +15000% | indirect |
| Jan 6, 2026 | Peterson Neil W.CHIEF OPERATING OFFICER · O | ▼ Sale | 5,000 | $90 | $450K | -15% | plan |
| Nov 25, 2025 | Lampropoulos Fred P.Executive Chairman · O·D | ▼ Sale | 10,000 | $88.04 | $880K | -1% | — |
| Nov 21, 2025 | Lampropoulos Fred P.Executive Chairman · O·D | ▼ Sale | 25,000 | $87.31 | $2.2M | -2.4% | — |
| Nov 20, 2025 | Lampropoulos Fred P.Executive Chairman · O·D | ▼ Sale | 20,000 | $85.13 | $1.7M | -1.9% | — |
| Nov 18, 2025 | Lampropoulos Fred P.Executive Chairman · O·D | ▼ Sale | 5,000 | $84.83 | $424K | -0.5% | — |
| Aug 22, 2025 | Ward Lynne N.D | ▼ Sale | 3,000 | $88.56 | $266K | -19% | — |
| Aug 11, 2025 | Ward Lynne N.D | ▼ Sale | 2,433 | $84.89 | $207K | -16% | — |
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Merit Medical Systems filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $MMSI feed.